SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026360
Filing Date
2018-11-02
Accepted
2018-11-02 06:05:55
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q epzm-10q_20180930.htm 10-Q 1637559
2 EX-10.1 epzm-ex101_26.htm EX-10.1 34910
3 EX-31.1 epzm-ex311_8.htm EX-31.1 8516
4 EX-31.2 epzm-ex312_6.htm EX-31.2 8503
5 EX-32.1 epzm-ex321_7.htm EX-32.1 6229
  Complete submission text file 0001564590-18-026360.txt   5555126

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT epzm-20180930.xml EX-101.INS 1143571
7 XBRL TAXONOMY EXTENSION SCHEMA epzm-20180930.xsd EX-101.SCH 40977
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20180930_cal.xml EX-101.CAL 35505
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20180930_def.xml EX-101.DEF 132271
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20180930_lab.xml EX-101.LAB 314330
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20180930_pre.xml EX-101.PRE 231310
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 181155442
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1